Thad Huston
Equibles does not estimate personal net worth.
Get an email with a short summary when Artiva Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ARTV alertsAbout Thad Huston
Thad Huston is recorded as CFO at Artiva Biotherapeutics, Inc. (ARTV) since February 18, 2026. Artiva Biotherapeutics, Inc. reported in an 8-K filed February 24, 2026 that Thad Huston was appointed Chief Financial Officer, effective February 18, 2026. Artiva Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Artiva Biotherapeutics, Inc. includes Fred Aslan (CEO and Board Member), Fred Aslan, M.D. (CFO), Neha Krishnamohan (CFO) and 7 others.
“On February 24, 2026, Artiva Biotherapeutics, Inc. (the "Company") announced that its Board of Directors (the "Board") appointed Thad Huston as the Company's Chief Financial Officer.”
Affiliation history
-
Current
2026-02-18–present
Company network
Leadership on record at Artiva Biotherapeutics, Inc.
- Fred Aslan CEO, Board Member
- Fred Aslan, M.D. CFO
- Neha Krishnamohan CFO
- Jennifer Bush COO
- Alison Moore, Ph.D. Board Member
- Brian Daniels, M.D. Board Member
- Daniel Baker Board Member
- Daniel Baker, Ph.D. Board Member
- Elaine Sorg Board Member
- Laura Stoppel, Ph.D. Board Member